You are here:

Publications Health

Audit Process efficiency in the replacement of the reporting platform for therapeutic products - Federal Office for National Economic Supply

Audit number: 21439

At the end of 2021, around 11,500 human medicines were authorised in Switzerland; the uninterrupted supply of these is not guaranteed. This is not a phenomenon of the recent COVID-19 pandemic, but has been an ever-increasing concern for the therapeutic products industry, hospitals and doctors for around 20 years.